Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Type 2 diabetes
Pharma
Europe's CHMP gives nods to Novo's Kyinsu, Bayer's Lynkuet
Europe's CHMP has recommended several products for approval, including Novo Nordisk's diabetes drug Kyinsu and Bayer's menopause treatment Lynkuet.
Kevin Dunleavy
Sep 19, 2025 10:45am
Lilly's Mounjaro scores in Type 2 diabetes trial in kids 10-17
Sep 18, 2025 11:22am
Lilly pauses UK orders on its diabetes and obesity med Mounjaro
Aug 28, 2025 11:08am
Fierce Biotech
Lilly's oral GLP-1 charts 10.5% weight loss in diabetic patients
Aug 26, 2025 6:45am
Mounjaro measures up to Trulicity in Eli Lilly cardio trial
Jul 31, 2025 8:12am
RemeGen, Harbour, Datroway—Fierce Pharma Asia
Jun 27, 2025 8:37am
